Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2015 (2015), Article ID 854621, 5 pages
http://dx.doi.org/10.1155/2015/854621
Research Article

Association between Programmed Cell Death 6 Interacting Protein Insertion/Deletion Polymorphism and the Risk of Breast Cancer in a Sample of Iranian Population

1Cellular and Molecular Research Center, Zahedan University of Medical Sciences, Zahedan, Iran
2Department of Clinical Biochemistry, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran
3Department of Internal Medicine, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran
4Genetic of Non-Communicable Disease Research Center, Zahedan University of Medical Sciences, Zahedan, Iran
5Department of Human Anatomy and Cell Science, College of Medicine, Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada R3E 0J9
6Manitoba Institute of Child Health, University of Manitoba, Winnipeg, MB, Canada R3E 0J9
7Health Policy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

Received 13 January 2015; Revised 1 April 2015; Accepted 15 April 2015

Academic Editor: Grant Izmirlian

Copyright © 2015 Mohammad Hashemi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Turashvili, J. Bouchal, G. Burkadze, and Z. Kolar, “Differentiation of tumours of ductal and lobular origin: II. Genomics of invasive ductal and lobular breast carcinomas,” Biomedical Papers of the Medical Faculty of the University Palacký, vol. 149, no. 1, pp. 63–68, 2005. View at Google Scholar
  2. J. T. Wu and J. G. Kral, “The NF-κB/IκB signaling system: a molecular target in breast cancer therapy,” Journal of Surgical Research, vol. 123, no. 1, pp. 158–169, 2005. View at Publisher · View at Google Scholar
  3. M. Hashemi, S. Amininia, M. Ebrahimi, S. M. Hashemi, M. Taheri, and S. Ghavami, “Association between hTERT polymorphisms and the risk of breast cancer in a sample of Southeast Iranian population,” BMC Research Notes, vol. 7, no. 1, article 895, 2014. View at Publisher · View at Google Scholar
  4. G. R. Babu, G. Samari, S. P. Cohen et al., “Breast cancer screening among females in iran and recommendations for improved practice: a review,” Asian Pacific Journal of Cancer Prevention, vol. 12, no. 7, pp. 1647–1655, 2011. View at Google Scholar · View at Scopus
  5. S. Kolahdoozan, A. Sadjadi, A. R. Radmard, and H. Khademi, “Five common cancers in Iran,” Archives of Iranian Medicine, vol. 13, no. 2, pp. 143–146, 2010. View at Google Scholar · View at Scopus
  6. M. Hashemi, A. Fazaeli, S. Ghavami et al., “Functional polymorphisms of FAS and FASL gene and risk of breast cancer—pilot study of 134 cases,” PLoS ONE, vol. 8, no. 1, Article ID e53075, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Hashemi, M. E. Omrani, E. Eskanadri-Nasab, S. S. Hasani, M. A. Mashhadi, and M. Taheri, “A 40-bp insertion/deletion polymorphism of murine double minute2 (MDM2) increased the risk of breast cancer in Zahedan, Southeast Iran,” Iranian Biomedical Journal, vol. 18, no. 4, pp. 245–249, 2014. View at Publisher · View at Google Scholar
  8. M. Omrani, M. Hashemi, E. Eskandari-Nasab et al., “Hsa-mir-499 rs3746444 gene polymorphism is associated with susceptibility to breast cancer in an Iranian population,” Biomarkers in Medicine, vol. 8, no. 2, pp. 259–267, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. S.-G. Liu, S.-H. Yuan, H.-Y. Wu, C.-S. Huang, and J. Liu, “The programmed cell death 6 interacting protein insertion/deletion polymorphism is associated with non-small cell lung cancer risk in a Chinese Han population,” Tumor Biology, vol. 35, no. 9, pp. 8679–8683, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. I. Rashedi, S. Panigrahi, P. Ezzati, S. Ghavami, and M. Los, “Autoimmunity and apoptosis—therapeutic implications,” Current Medicinal Chemistry, vol. 14, no. 29, pp. 3139–3151, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. W. Chaabane, A. Cieślar-Pobuda, M. El-Gazzah et al., “Human-gyrovirus-Apoptin triggers mitochondrial death pathway—Nur77 is required for apoptosis triggering,” Neoplasia, vol. 16, no. 9, pp. 679–693, 2014. View at Publisher · View at Google Scholar
  12. O. M. Rollano Peñaloza, M. Lewandowska, J. Stetefeld et al., “Apoptins: selective anticancer agents,” Trends in Molecular Medicine, vol. 20, no. 9, pp. 519–528, 2014. View at Publisher · View at Google Scholar
  13. S. Ghavami, C. Kerkhoff, M. Los, M. Hashemi, C. Sorg, and F. Karami-Tehrani, “Mechanism of apoptosis induced by S100A8/A9 in colon cancer cell lines: the role of ROS and the effect of metal ions,” Journal of Leukocyte Biology, vol. 76, no. 1, pp. 169–175, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Ghavami, M. Hashemi, S. R. Ande et al., “Apoptosis and cancer: mutations within caspase genes,” Journal of Medical Genetics, vol. 46, no. 8, pp. 497–510, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Ghavami, M. M. Mutawe, K. Hauff et al., “Statin-triggered cell death in primary human lung mesenchymal cells involves p53-PUMA and release of Smac and Omi but not cytochrome c,” Biochimica et Biophysica Acta, vol. 1803, no. 4, pp. 452–467, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Ghavami, M. M. Mutawe, P. Sharma et al., “Mevalonate cascade regulation of airway mesenchymal cell autophagy and apoptosis: a dual role for p53,” PLoS ONE, vol. 6, no. 1, Article ID e16523, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Ghavami, P. Sharma, B. Yeganeh et al., “Airway mesenchymal cell death by mevalonate cascade inhibition: integration of autophagy, unfolded protein response and apoptosis focusing on Bcl2 family proteins,” Biochimica et Biophysica Acta: Molecular Cell Research, vol. 1843, no. 7, pp. 1259–1271, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Ghavami, C. Kerkhoff, W. J. Chazin et al., “S100A8/9 induces cell death via a novel, RAGE-independent pathway that involves selective release of Smac/DIABLO and Omi/HtrA2,” Biochimica et Biophysica Acta: Molecular Cell Research, vol. 1783, no. 2, pp. 297–311, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Ghavami, S. Shojaei, B. Yeganeh et al., “Autophagy and apoptosis dysfunction in neurodegenerative disorders,” Progress in Neurobiology, vol. 112, pp. 24–49, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Dasari and P. B. Tchounwou, “Cisplatin in cancer therapy: molecular mechanisms of action,” European Journal of Pharmacology, vol. 740, pp. 364–378, 2014. View at Publisher · View at Google Scholar
  21. M. Hassan, H. Watari, A. AbuAlmaaty, Y. Ohba, and N. Sakuragi, “Apoptosis and molecular targeting therapy in cancer,” BioMed Research International, vol. 2014, Article ID 150845, 23 pages, 2014. View at Publisher · View at Google Scholar
  22. Q. Yu, C. Zhou, J. Wang, L. Chen, S. Zheng, and J. Zhang, “A functional insertion/deletion polymorphism in the promoter of PDCD6IP is associated with the susceptibility of hepatocellular carcinoma in a Chinese population,” DNA and Cell Biology, vol. 32, no. 8, pp. 451–457, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Hashemi, E. Eskandari-Nasab, A. Fazaeli et al., “Association of genetic polymorphisms of glutathione-S-transferase genes (GSTT1, GSTM1, and GSTP1) and susceptibility to nonalcoholic fatty liver disease in Zahedan, Southeast Iran,” DNA and Cell Biology, vol. 31, no. 5, pp. 672–677, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Gonzalez-Neira, J. M. Rosa-Rosa, A. Osorio et al., “Genomewide high-density SNP linkage analysis of non-BRCA1/2 breast cancer families identifies various candidate regions and has greater power than microsatellite studies,” BMC Genomics, vol. 8, article 299, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. J. A. Badner, D. Koller, T. Foroud et al., “Genome-wide linkage analysis of 972 bipolar pedigrees using single-nucleotide polymorphisms,” Molecular Psychiatry, vol. 17, no. 8, pp. 818–826, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. Wu, S. Pan, S. Che et al., “Overexpression of Hp95 induces G1 phase arrest in confluent HeLa cells,” Differentiation, vol. 67, no. 4-5, pp. 139–153, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. Wu, S. Pan, W. Luo, S.-H. Lin, and J. Kuang, “Hp95 promotes anoikis and inhibits tumorigenicity of HeLa cells,” Oncogene, vol. 21, no. 44, pp. 6801–6808, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. P. Vito, L. Pellegrini, C. Guiet, and L. D'Adamio, “Cloning of AIP1, a novel protein that associates with the apoptosis-linked gene ALG-2 in a Ca2+-dependent reaction,” The Journal of Biological Chemistry, vol. 274, no. 3, pp. 1533–1540, 1999. View at Publisher · View at Google Scholar · View at Scopus
  29. A. M. Martin and B. L. Weber, “Genetic and hormonal risk factors in breast cancer,” Journal of the National Cancer Institute, vol. 92, no. 14, pp. 1126–1135, 2000. View at Publisher · View at Google Scholar · View at Scopus
  30. E. Wiechec, “Implications of genomic instability in the diagnosis and treatment of breast cancer,” Expert Review of Molecular Diagnostics, vol. 11, no. 4, pp. 445–453, 2011. View at Publisher · View at Google Scholar · View at Scopus